Cortexyme CRTX

$ 1.88 -1.05%

Quarterly report 2024-Q3
added 11-13-2024

Cortexyme Balance Sheet 2011-2024 | CRTX

Annual Balance Sheet Cortexyme

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-68.6 M	-66.6 M	-51.2 M	-24.9 M	-172 K	-	-	-	-	-	-
Long Term Debt	13.4 M	-	420 K	-	-	-	7.17 M	-	-	-	-	-	-
Long Term Debt Current	64 K	377 K	741 K	238 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	208 K	-	-	26.2 M	-	-	-	-	-	-
Total Current Liabilities	9.57 M	3.07 M	14.2 M	17 M	8.89 M	-	-	-	-	-	-	-	-
Total Liabilities	82.8 M	3.32 M	14.6 M	17.2 M	8.89 M	1.46 M	28 M	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-320 M	-288 M	-237 M	-147 M	-69.8 M	-32.8 M	-20.3 M	-	-	-	-	-	-
Total Assets	168 M	104 M	133 M	189 M	124 M	72.9 M	7.72 M	-	-	-	-	-	-
Cash and Cash Equivalents	20.8 M	44.6 M	69.7 M	66.8 M	51.2 M	24.9 M	7.39 M	-	-	-	-	-	-
Book Value	85.1 M	101 M	119 M	172 M	115 M	71.4 M	-20.3 M	-	-	-	-	-	-
Total Shareholders Equity	85.1 M	101 M	119 M	172 M	115 M	-32.6 M	-20.3 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Cortexyme

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	14.9 M	13.8 M	13.5 M	13.4 M	-	-	-	-	19 K	38 K	40 K	-	610 K	773 K	171 K	208 K	208 K	208 K	208 K	-	-	-	475 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	81.6 M	87.9 M	85.1 M	82.8 M	2.25 M	1.95 M	3.12 M	3.32 M	5.25 M	6.33 M	9.75 M	14.6 M	14.8 M	19.3 M	18 M	17.2 M	17.2 M	17.2 M	17.2 M	8.89 M	8.89 M	8.89 M	8.89 M	1.46 M	1.46 M	1.46 M	1.46 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-364 M	-359 M	-331 M	-320 M	-311 M	-305 M	-301 M	-288 M	-283 M	-275 M	-258 M	-237 M	-213 M	-191 M	-170 M	-147 M	-147 M	-147 M	-147 M	-69.8 M	-69.8 M	-69.8 M	-69.8 M	-32.8 M	-32.8 M	-32.8 M	-32.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	127 M	135 M	159 M	168 M	85.4 M	88.8 M	93.3 M	104 M	110 M	118 M	116 M	133 M	147 M	161 M	175 M	189 M	189 M	189 M	189 M	124 M	124 M	124 M	124 M	72.9 M	72.9 M	72.9 M	72.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	2.68 M	7.89 M	21.8 M	20.8 M	21.6 M	22.6 M	46.7 M	40.6 M	31.8 M	46.9 M	67.6 M	29.5 M	62.2 M	74 M	85.3 M	66.8 M	64.2 M	66.2 M	85.6 M	51.2 M	44.7 M	51.2 M	51.2 M	24.9 M	24.9 M	24.9 M	24.9 M	7.39 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	44.9 M	47 M	74.2 M	85.1 M	83.1 M	86.9 M	90.2 M	101 M	105 M	112 M	106 M	119 M	133 M	142 M	156 M	172 M	172 M	172 M	172 M	115 M	115 M	115 M	115 M	71.4 M	71.4 M	71.4 M	71.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	44.9 M	47 M	74.2 M	85.1 M	83.1 M	86.9 M	90.2 M	101 M	105 M	112 M	106 M	119 M	133 M	142 M	156 M	172 M	172 M	172 M	172 M	115 M	115 M	115 M	115 M	-32.6 M	-32.6 M	-32.6 M	-32.6 M	-20.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency